Journal Article Ahead of print
PubMed: 42126061 DOI: 10.1093/bjs/znag061
Chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer (GRECCAR 15): superiority open-label phase III randomized clinical trial.
Br J Surg
Authors: Quentin Denost, Laurent Ghouti, Jean-Jacques Tuech, Philippe Rouanet, Adeline Germain, Emmanuel Rio, Jean-Luc Faucheron, Mehrdad Jafari, Eddy Cotte, Laurent Mineur, Cécile De Chaisemartin, Jérémie H Lefevre, Aude Merdrignac, Remi Sitta, Eric Frison, Véronique Vendrely
Affiliations
- Clinique Tivoli-Ducos, Bordeaux Colorectal Institute, Bordeaux.
- Department of surgery, Centre Hospitalier Purpan, Toulouse.
- Department of surgery, University Hospital Center of Rouen, Rouen.
- Department of surgery, Institut du Cancer de Montpellier, Montpellier.
- Department of surgery, University Hospital of Nancy-Brabois, Nancy.
- Department of Radiation Oncology, Institut de Cancérologie de l'Ouest, Saint Herblain.
- Department of Digestive and Emergency Surgery, Grenoble Alpes University Hospital, Grenoble.
- Department of surgery, Center Oscar Lambret, LILLE.
- Department of Digestive Surgery, Hospices Civils de Lyon, LYON.
- Department of Radiation Oncology, Institut Sainte Catherine, Avignon.
- Department of surgery, Institut Paoli Calmettes, Marseille.
- Sorbonne Université, Department of Digestive Surgery, AP-HP, Hôpital Saint Antoine, F-75012, Paris, France.
- Department of surgery, CHU Rennes, Rennes.
- CHU Bordeaux, Service d'information médicale, Bordeaux, France.
- Department of Radiation Oncology, CHU Bordeaux, Bordeaux, Bordeaux, France.
MeSH
Neoplasms, Drug Therapy, Re-Irradiation, Rectal Neoplasms, Therapeutics, Chemotherapy